Concepts (233)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Hypoxia-Ischemia, Brain | 3 | 2018 | 86 | 2.00 | Why? |
| Asphyxia | 3 | 2017 | 28 | 1.99 | Why? |
| Asphyxia Neonatorum | 4 | 2018 | 17 | 1.81 | Why? |
| Hernias, Diaphragmatic, Congenital | 2 | 2019 | 54 | 1.48 | Why? |
| Enterocolitis, Necrotizing | 2 | 2019 | 71 | 1.48 | Why? |
| Nitric Oxide | 4 | 2019 | 769 | 1.45 | Why? |
| Intensive Care Units, Neonatal | 7 | 2019 | 749 | 1.35 | Why? |
| Hypothermia, Induced | 3 | 2018 | 176 | 1.32 | Why? |
| Intensive Care, Neonatal | 3 | 2020 | 284 | 1.29 | Why? |
| Resuscitation | 4 | 2020 | 638 | 1.26 | Why? |
| Heart Arrest | 4 | 2017 | 1239 | 1.24 | Why? |
| Oximetry | 4 | 2018 | 658 | 1.17 | Why? |
| Sheep | 9 | 2019 | 420 | 1.16 | Why? |
| Infant, Premature | 6 | 2019 | 883 | 1.15 | Why? |
| Cardiopulmonary Resuscitation | 4 | 2017 | 1876 | 1.03 | Why? |
| Persistent Fetal Circulation Syndrome | 2 | 2019 | 9 | 0.98 | Why? |
| Glucose | 2 | 2017 | 573 | 0.97 | Why? |
| Hypoglycemia | 2 | 2017 | 406 | 0.94 | Why? |
| Meconium Aspiration Syndrome | 2 | 2018 | 4 | 0.93 | Why? |
| Infant, Newborn, Diseases | 3 | 2021 | 394 | 0.90 | Why? |
| Oxygen | 4 | 2019 | 3715 | 0.88 | Why? |
| Infant, Newborn | 27 | 2021 | 23105 | 0.86 | Why? |
| Infant, Extremely Premature | 3 | 2019 | 144 | 0.85 | Why? |
| Fetal Hemoglobin | 1 | 2020 | 22 | 0.85 | Why? |
| Delivery Rooms | 2 | 2018 | 148 | 0.77 | Why? |
| Cyclic GMP | 1 | 2019 | 50 | 0.77 | Why? |
| Hemodynamics | 2 | 2018 | 1562 | 0.77 | Why? |
| Meconium | 1 | 2018 | 8 | 0.74 | Why? |
| Premedication | 1 | 2018 | 40 | 0.73 | Why? |
| Respiratory Distress Syndrome, Newborn | 2 | 2019 | 124 | 0.73 | Why? |
| Hypothermia | 1 | 2018 | 59 | 0.72 | Why? |
| Epinephrine | 2 | 2017 | 323 | 0.70 | Why? |
| Brain Waves | 1 | 2017 | 37 | 0.67 | Why? |
| Neonatal Screening | 2 | 2017 | 285 | 0.67 | Why? |
| Capnography | 1 | 2017 | 32 | 0.66 | Why? |
| Amniotic Fluid | 1 | 2018 | 249 | 0.63 | Why? |
| Models, Animal | 1 | 2018 | 788 | 0.57 | Why? |
| Microcirculation | 1 | 2019 | 447 | 0.56 | Why? |
| Hypertension, Pulmonary | 3 | 2018 | 970 | 0.54 | Why? |
| Animals, Newborn | 4 | 2017 | 350 | 0.51 | Why? |
| Reactive Oxygen Species | 1 | 2019 | 1136 | 0.49 | Why? |
| Intestines | 1 | 2019 | 817 | 0.48 | Why? |
| Hemoglobins | 1 | 2018 | 958 | 0.48 | Why? |
| Interdisciplinary Communication | 1 | 2020 | 1425 | 0.48 | Why? |
| Risk Management | 1 | 2020 | 1044 | 0.47 | Why? |
| Cooperative Behavior | 1 | 2020 | 1216 | 0.47 | Why? |
| Pregnancy Complications, Infectious | 4 | 2021 | 11559 | 0.45 | Why? |
| Heart Defects, Congenital | 2 | 2017 | 933 | 0.43 | Why? |
| Video Recording | 1 | 2017 | 786 | 0.42 | Why? |
| Disease Models, Animal | 7 | 2019 | 10998 | 0.41 | Why? |
| Premature Birth | 2 | 2019 | 2151 | 0.40 | Why? |
| Electroencephalography | 1 | 2017 | 1242 | 0.39 | Why? |
| Positive-Pressure Respiration | 1 | 2018 | 1160 | 0.39 | Why? |
| Infectious Disease Transmission, Vertical | 3 | 2021 | 5164 | 0.38 | Why? |
| Bronchopulmonary Dysplasia | 2 | 2019 | 53 | 0.38 | Why? |
| Analgesics, Opioid | 1 | 2018 | 1070 | 0.35 | Why? |
| Age of Onset | 2 | 2020 | 557 | 0.34 | Why? |
| Patient Care Team | 1 | 2020 | 3556 | 0.30 | Why? |
| Intubation, Intratracheal | 2 | 2018 | 3962 | 0.29 | Why? |
| Extracorporeal Membrane Oxygenation | 3 | 2018 | 5002 | 0.28 | Why? |
| Pregnancy | 9 | 2021 | 23879 | 0.28 | Why? |
| Gestational Age | 3 | 2019 | 1488 | 0.27 | Why? |
| Blood Gas Analysis | 2 | 2018 | 893 | 0.26 | Why? |
| Oxygen Inhalation Therapy | 1 | 2017 | 3629 | 0.25 | Why? |
| Oxygen Consumption | 2 | 2019 | 711 | 0.25 | Why? |
| Trachea | 2 | 2017 | 894 | 0.23 | Why? |
| Carbon Dioxide | 2 | 2018 | 917 | 0.22 | Why? |
| Rats | 2 | 2019 | 2764 | 0.22 | Why? |
| Milk, Human | 2 | 2021 | 956 | 0.22 | Why? |
| Lung | 3 | 2019 | 31049 | 0.22 | Why? |
| Endothelins | 1 | 2019 | 21 | 0.20 | Why? |
| Plaque, Amyloid | 1 | 2019 | 33 | 0.20 | Why? |
| Animals | 12 | 2019 | 78931 | 0.20 | Why? |
| Infant, Very Low Birth Weight | 1 | 2019 | 62 | 0.19 | Why? |
| Indomethacin | 1 | 2019 | 47 | 0.19 | Why? |
| Catecholamines | 1 | 2019 | 66 | 0.19 | Why? |
| Organizational Case Studies | 1 | 2020 | 293 | 0.19 | Why? |
| Infant, Premature, Diseases | 1 | 2019 | 74 | 0.19 | Why? |
| Free Radicals | 1 | 2018 | 55 | 0.19 | Why? |
| Peptidyl-Dipeptidase A | 1 | 2020 | 9659 | 0.18 | Why? |
| Humans | 40 | 2021 | 930598 | 0.18 | Why? |
| Hernia, Inguinal | 1 | 2019 | 51 | 0.18 | Why? |
| Lactation | 1 | 2021 | 361 | 0.18 | Why? |
| Natriuretic Peptide, C-Type | 1 | 2017 | 4 | 0.18 | Why? |
| Umbilical Veins | 1 | 2017 | 14 | 0.17 | Why? |
| Herniorrhaphy | 1 | 2019 | 99 | 0.17 | Why? |
| Receptor, Muscarinic M3 | 1 | 2016 | 5 | 0.17 | Why? |
| Benzylamines | 1 | 2016 | 8 | 0.17 | Why? |
| Vasoconstriction | 1 | 2019 | 153 | 0.17 | Why? |
| Instillation, Drug | 1 | 2017 | 28 | 0.17 | Why? |
| Oxidative Stress | 2 | 2019 | 2050 | 0.17 | Why? |
| Fetal Growth Retardation | 1 | 2019 | 217 | 0.16 | Why? |
| Acidosis, Lactic | 1 | 2017 | 83 | 0.16 | Why? |
| Maternal Age | 1 | 2018 | 244 | 0.16 | Why? |
| Acidosis | 1 | 2018 | 125 | 0.16 | Why? |
| Pneumonia, Viral | 8 | 2020 | 243684 | 0.16 | Why? |
| Nitric Oxide Synthase Type III | 1 | 2016 | 87 | 0.16 | Why? |
| SARS Virus | 1 | 2020 | 13021 | 0.16 | Why? |
| Arginine | 1 | 2019 | 377 | 0.15 | Why? |
| Coronavirus Infections | 8 | 2020 | 253789 | 0.15 | Why? |
| Suction | 1 | 2018 | 297 | 0.15 | Why? |
| Vasodilator Agents | 1 | 2019 | 344 | 0.15 | Why? |
| Pulmonary Gas Exchange | 1 | 2018 | 414 | 0.15 | Why? |
| Nerve Block | 1 | 2019 | 183 | 0.15 | Why? |
| Aspergillosis | 1 | 2019 | 264 | 0.15 | Why? |
| Pandemics | 8 | 2020 | 389249 | 0.14 | Why? |
| Anesthesia, Conduction | 1 | 2019 | 235 | 0.14 | Why? |
| Random Allocation | 1 | 2017 | 773 | 0.14 | Why? |
| Airway Extubation | 1 | 2019 | 403 | 0.14 | Why? |
| Protective Factors | 1 | 2020 | 1720 | 0.13 | Why? |
| Data Interpretation, Statistical | 1 | 2018 | 657 | 0.13 | Why? |
| Steroids | 1 | 2019 | 904 | 0.13 | Why? |
| Administration, Intravenous | 1 | 2017 | 1115 | 0.13 | Why? |
| Hypoxia | 2 | 2018 | 3626 | 0.12 | Why? |
| Vasoconstrictor Agents | 1 | 2017 | 714 | 0.12 | Why? |
| Infusions, Intravenous | 1 | 2017 | 1224 | 0.12 | Why? |
| Respiration | 1 | 2018 | 729 | 0.12 | Why? |
| Guanidines | 1 | 2016 | 499 | 0.12 | Why? |
| Female | 16 | 2021 | 380317 | 0.12 | Why? |
| Bronchodilator Agents | 1 | 2017 | 444 | 0.12 | Why? |
| Evidence-Based Practice | 1 | 2018 | 693 | 0.11 | Why? |
| Drug Approval | 1 | 2021 | 1325 | 0.11 | Why? |
| Neuropsychological Tests | 1 | 2017 | 954 | 0.11 | Why? |
| Health Expenditures | 1 | 2019 | 904 | 0.11 | Why? |
| Dogs | 1 | 2019 | 2529 | 0.11 | Why? |
| Infection Control | 1 | 2020 | 23131 | 0.11 | Why? |
| Communicable Disease Control | 1 | 2020 | 29620 | 0.10 | Why? |
| Child | 6 | 2020 | 70012 | 0.10 | Why? |
| Hand Disinfection | 1 | 2020 | 1671 | 0.10 | Why? |
| Treatment Outcome | 6 | 2019 | 51732 | 0.10 | Why? |
| Pain Management | 1 | 2019 | 854 | 0.10 | Why? |
| Neoplasms | 1 | 2018 | 17251 | 0.10 | Why? |
| Hospitals, Pediatric | 1 | 2020 | 1792 | 0.10 | Why? |
| Antioxidants | 1 | 2019 | 1593 | 0.09 | Why? |
| Endoscopy, Gastrointestinal | 1 | 2020 | 1545 | 0.09 | Why? |
| Cesarean Section | 1 | 2019 | 2089 | 0.09 | Why? |
| Blood Pressure | 2 | 2017 | 2198 | 0.09 | Why? |
| Mothers | 1 | 2019 | 1624 | 0.09 | Why? |
| Perioperative Care | 1 | 2019 | 1329 | 0.09 | Why? |
| Seasons | 1 | 2021 | 4071 | 0.09 | Why? |
| Image Processing, Computer-Assisted | 1 | 2017 | 1383 | 0.09 | Why? |
| Seizures | 1 | 2017 | 1163 | 0.09 | Why? |
| Academic Medical Centers | 1 | 2020 | 3088 | 0.09 | Why? |
| Asymptomatic Diseases | 1 | 2020 | 3444 | 0.08 | Why? |
| Guidelines as Topic | 1 | 2020 | 2844 | 0.08 | Why? |
| Betacoronavirus | 8 | 2020 | 204454 | 0.08 | Why? |
| Disinfection | 1 | 2020 | 2912 | 0.08 | Why? |
| New York City | 1 | 2020 | 7432 | 0.08 | Why? |
| Infant | 2 | 2020 | 30274 | 0.08 | Why? |
| Endothelial Cells | 1 | 2016 | 2048 | 0.08 | Why? |
| Monitoring, Physiologic | 1 | 2017 | 1956 | 0.08 | Why? |
| Smoking | 1 | 2019 | 3358 | 0.07 | Why? |
| Clinical Decision-Making | 1 | 2019 | 3755 | 0.07 | Why? |
| Child, Preschool | 2 | 2020 | 36283 | 0.07 | Why? |
| Antihypertensive Agents | 1 | 2016 | 1962 | 0.07 | Why? |
| California | 2 | 2021 | 2047 | 0.06 | Why? |
| Male | 9 | 2021 | 367725 | 0.06 | Why? |
| Risk Assessment | 4 | 2021 | 25439 | 0.06 | Why? |
| Skin Diseases | 1 | 2019 | 2509 | 0.06 | Why? |
| Education, Medical | 1 | 2019 | 2461 | 0.06 | Why? |
| Severity of Illness Index | 3 | 2020 | 48226 | 0.06 | Why? |
| Prospective Studies | 2 | 2017 | 43301 | 0.06 | Why? |
| Systemic Inflammatory Response Syndrome | 1 | 2021 | 6653 | 0.05 | Why? |
| Back | 1 | 2019 | 10 | 0.05 | Why? |
| Magnetic Resonance Imaging | 1 | 2017 | 6551 | 0.05 | Why? |
| Length of Stay | 1 | 2018 | 11042 | 0.05 | Why? |
| Retrospective Studies | 4 | 2019 | 105322 | 0.05 | Why? |
| Respiratory Tract Infections | 1 | 2021 | 6817 | 0.05 | Why? |
| Heart Diseases | 1 | 2017 | 3503 | 0.05 | Why? |
| Mice | 1 | 2019 | 21357 | 0.05 | Why? |
| Infant, Small for Gestational Age | 1 | 2019 | 151 | 0.05 | Why? |
| Prognosis | 2 | 2019 | 32490 | 0.05 | Why? |
| Personal Protective Equipment | 2 | 2020 | 15978 | 0.05 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2018 | 10649 | 0.05 | Why? |
| Financing, Personal | 1 | 2019 | 113 | 0.04 | Why? |
| Follow-Up Studies | 1 | 2017 | 17020 | 0.04 | Why? |
| Terbutaline | 1 | 2017 | 35 | 0.04 | Why? |
| Pertussis Toxin | 1 | 2017 | 19 | 0.04 | Why? |
| Prevalence | 1 | 2020 | 25773 | 0.04 | Why? |
| Oncogene Protein v-akt | 1 | 2016 | 10 | 0.04 | Why? |
| Birth Weight | 1 | 2019 | 250 | 0.04 | Why? |
| Analgesics, Non-Narcotic | 1 | 2019 | 164 | 0.04 | Why? |
| Masks | 1 | 2020 | 8528 | 0.04 | Why? |
| Maternal Exposure | 1 | 2019 | 173 | 0.04 | Why? |
| Pregnancy Trimester, First | 1 | 2019 | 366 | 0.04 | Why? |
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 9706 | 0.04 | Why? |
| Respiration, Artificial | 2 | 2019 | 22116 | 0.04 | Why? |
| Cell Hypoxia | 1 | 2016 | 141 | 0.04 | Why? |
| Inflammation | 1 | 2019 | 13255 | 0.04 | Why? |
| Cohort Studies | 1 | 2019 | 36005 | 0.04 | Why? |
| Italy | 1 | 2020 | 38444 | 0.04 | Why? |
| Pain Measurement | 1 | 2019 | 533 | 0.04 | Why? |
| Pulmonary Surfactants | 1 | 2017 | 128 | 0.04 | Why? |
| Anxiety | 1 | 2019 | 17311 | 0.03 | Why? |
| Quarantine | 1 | 2021 | 18418 | 0.03 | Why? |
| Critical Illness | 1 | 2017 | 17281 | 0.03 | Why? |
| Comorbidity | 1 | 2018 | 34796 | 0.03 | Why? |
| Practice Guidelines as Topic | 1 | 2018 | 15421 | 0.03 | Why? |
| United States | 1 | 2020 | 46150 | 0.03 | Why? |
| Risk Factors | 2 | 2020 | 71621 | 0.03 | Why? |
| New York | 1 | 2019 | 2488 | 0.03 | Why? |
| Administration, Inhalation | 1 | 2017 | 1647 | 0.03 | Why? |
| Smoking Cessation | 1 | 2019 | 826 | 0.03 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.03 | Why? |
| Adult | 4 | 2021 | 244371 | 0.03 | Why? |
| Breast Feeding | 1 | 2021 | 1585 | 0.03 | Why? |
| Teaching | 1 | 2019 | 1208 | 0.02 | Why? |
| Interviews as Topic | 1 | 2019 | 1952 | 0.02 | Why? |
| Pulmonary Artery | 1 | 2016 | 803 | 0.02 | Why? |
| Immunohistochemistry | 1 | 2017 | 2275 | 0.02 | Why? |
| Endoscopy | 1 | 2020 | 1564 | 0.02 | Why? |
| Feasibility Studies | 1 | 2019 | 3467 | 0.02 | Why? |
| Hydrocortisone | 1 | 2019 | 1790 | 0.02 | Why? |
| Clinical Protocols | 1 | 2020 | 2734 | 0.02 | Why? |
| Methylprednisolone | 1 | 2019 | 2107 | 0.02 | Why? |
| Antifungal Agents | 1 | 2019 | 1828 | 0.02 | Why? |
| Combined Modality Therapy | 1 | 2017 | 3395 | 0.02 | Why? |
| Dexamethasone | 1 | 2019 | 2055 | 0.02 | Why? |
| Quality of Health Care | 1 | 2019 | 1948 | 0.02 | Why? |
| Pilot Projects | 1 | 2019 | 5182 | 0.02 | Why? |
| Qualitative Research | 1 | 2019 | 4337 | 0.02 | Why? |
| Patient Selection | 1 | 2021 | 4560 | 0.02 | Why? |
| Risk | 1 | 2018 | 5288 | 0.02 | Why? |
| Logistic Models | 1 | 2019 | 9089 | 0.02 | Why? |
| Clinical Competence | 1 | 2019 | 3263 | 0.02 | Why? |
| Clinical Trials as Topic | 1 | 2021 | 7330 | 0.01 | Why? |
| Cell Line | 1 | 2016 | 12040 | 0.01 | Why? |
| Anti-Inflammatory Agents | 1 | 2019 | 6153 | 0.01 | Why? |
| Signal Transduction | 1 | 2016 | 7207 | 0.01 | Why? |
| Adolescent | 2 | 2021 | 86841 | 0.01 | Why? |
| Time Factors | 1 | 2019 | 31397 | 0.01 | Why? |
| Middle Aged | 2 | 2021 | 270681 | 0.01 | Why? |
| Young Adult | 1 | 2019 | 93724 | 0.01 | Why? |
Lakshminrusimha's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(233)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(63)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_